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human bone marrow derived mesenchymal stem cells (BMSC). Numerous chemically distinct lipid species 
were quantified and the changes in their relative amounts i.e. in the cell’s lipid profile after sequential passaging 
were followed until senescence (usually from passage 4 up to passage 10, in some cases until p14). 
Subsequently, the total lipids extracted from the cell pellets were analyzed by triple quadrupole ESI-MS 
equipment and using lipid-class specific scanning modes. The BMSC lines studied originated from ten donors, 
five of which were young and five elderly individuals.   
     In culture, the BMSC from both young and aged donors showed time-dependent changes in their 
phospholipid profiles. The clearest marker findings among individual lipid species were that in 
phosphatidylcholines (PC) and phosphatidylethanolamines (PE), the species 38:4 (acyl chain pair 18:0/20:4n-6) 
largely increased towards the late passages, which was seen in the BMSC derived from both the young or aged 
donors. Thus the reserves of 20:4n-6, the precursor of the eicosanoids having antiproliferative, apoptotic and 
inflammatory cellular reactions, were increased towards late passages. At phospholipid class level, 
lysophosphatidylcholine (LysoPC) and phosphatidylinositol (PI) totals, and the ratio of total PI to total 
phosphatidylserine (PI:PS) were increased from early to latest passages. The results provide new lipid 
biomarkers to be used for stem cell quality control. The accumulation of polyunsaturated lipid species 
containing 20:4n-6 or the increase of PI: PS ratio could be potential markers for cell aging and the cells’ poor 
viability and functionality. The results can be used to develop efficient stem cell therapies and improve patient 
safety. 
Avainsanat ? Nyckelord ? Keywords 
Mesenchymal Stem Cells, Lipidomics, Phospholipids, Arachidonic Acid 
Säilytyspaikka ? Förvaringsställe ? Where deposited 
Faculty of Agriculture and Forestry 
Muita tietoja ? Övriga uppgifter ? Further information 
Reijo Käkelä, Docent University Lecturer (Supervisor) reijo.kakela@helsinki.fi 
Kari Elo, Department of Agricultural Sciences (Professor in charge) kari.elo@helsinki.fi 
 3 
ABBREVIATIONS 
BMSC = human bone marrow mesenchymal stem cell 
ESI-MS = electrospray ionization-mass spectrometry 
LysoPC = lysophosphatidylcholine 
PC = phosphatidylcholine 
PC1, PC2 = principal component 1, principal component 2 
PCA = principal component analysis 
PCe = phosphatidylcholine ether lipid 
PE = phosphatidylethanolamine 
PEe = phosphatidylethanolamine ether lipid 
PI = phosphatidylinositol 
PLA2 = phospholipase A2 
PS = phosphatidylserine 
 
 
 
 
 
 
 
 
 
 
  
 4 
 
Contents 
ABSTRACT ............................................................................................................................ 2 
ABBREVIATIONS ................................................................................................................ 3 
LIST OF TABLES ................................................................................................................. 6 
LIST OF FIGURES ............................................................................................................... 7 
ACKNOWLEDGMENT ...................................................................................................... 10 
1 Introduction .................................................................................................................. 11 
1.1 Lipids ................................................................................................................................ 11 
1.2 Composition & Classifications ..................................................................................... 11 
1.3 Functions of lipids .......................................................................................................... 15 
1.3.1 Lipids as Building Blocks ......................................................................................................... 16 
1.3.2 Lipids as Energy Stores ............................................................................................................ 16 
1.3.3 Lipids as Signaling Molecules ................................................................................................. 17 
1.4 Lipidomics ....................................................................................................................... 18 
1.5 Role of Lipids in Mesenchymal Stem Cells ................................................................ 18 
1.6 Objectives ........................................................................................................................ 19 
2 Materials and Methods ................................................................................................ 21 
2.1 Tissue Culture ................................................................................................................. 21 
2.2 Total Lipid Folch Extraction ........................................................................................ 22 
2.3 Lipid Standards .............................................................................................................. 22 
2.4 Triple quadrupole Mass Spectrometry (Tandem MS/MS) ..................................... 24 
2.5 Data Analysis .................................................................................................................. 26 
2.5.1 Acquisition of MS data ............................................................................................................. 26 
2.5.2 MS data analysis........................................................................................................................ 27 
2.5.3 Statistical analysis ..................................................................................................................... 28 
3 RESULTS ..................................................................................................................... 30 
 5 
3.1 BMSC Lipid Class Profile ............................................................................................. 30 
3.2 BMSC Molecular Species Profile in each phospholipid class ................................. 42 
3.2.1 Phosphatidylcholine diacyl (PC) species ................................................................................. 42 
3.2.2 Phosphatidylcholine ether lipid (PCe) species ........................................................................ 43 
3.2.3 Phosphatidylethanolamine diacyl (PE) species ....................................................................... 45 
3.2.4 Phosphatidylethanolamine ether lipid (PEe) species .............................................................. 46 
3.2.5 Phosphatidylinositol (PI) species ............................................................................................. 48 
3.2.6 Phosphatidylserine (PS) species ............................................................................................... 49 
3.2.7 Lysophosphatidylcholine (LysoPC) species ............................................................................ 51 
3.3 PCA................................................................................................................................... 52 
4 Discussion ..................................................................................................................... 58 
5 References .................................................................................................................... 66 
 
 6 
LIST OF TABLES 
 
Table 1 Structure of major phospholipid classes (modified King 2011) ........................... 15 
Table 2 Lipid species included in the cocktail of internal standards ................................ 23 
Table 3  Summary of the phospholipid class-specific scan modes .................................... 25 
 
 7 
LIST OF FIGURES 
Figure 1 Schematics of Classification of the Most Abundant Cellular Lipids (Adapted 
from Pursell, D. P. 2009) ..................................................................................................... 12 
Figure 2 Scanning modes of analysis in a triple-quadrupole mass spectrometer. 
(Adapted from P.R. Graves & T.J. Haystead 2002) ........................................................... 24 
Figure 3  MS/MS spectra of cell line 271 at passage 8 taken from MassLynx 4.0 the 
spectra are overlaid and partial with mass range of 700m/z – 900m/z. ........................... 27 
Figure 4 Mol% proportions of phospholipid classes detected in the BMSC samples from 
early to late passages of five young donors. ....................................................................... 31 
Figure 5 Mol% proportions of phospholipid classes detected in the BMSC samples from 
early to late passages of five aged cell lines. ...................................................................... 31 
Figure 6 Mol% proportions of diacyl and alkyl-acyl PC detected in the BMSC samples 
from early to late passages of five young donors. .............................................................. 32 
Figure 7 Mol% proportions of diacyl and alkyl-acyl PC detected in the BMSC samples 
from early to late passages of five aged donors.................................................................. 33 
Figure 8 Mol% proportions of LysoPC detected in the BMSC samples from early to late 
passages of five young donors.............................................................................................. 34 
Figure 9 Mol% proportions of LysoPC detected in the BMSC samples from early to late 
passages of five aged donors. ............................................................................................... 34 
Figure 10 Mol% proportions of diacyl PE detected in the BMSC samples from early to 
late passages of five young donors. ..................................................................................... 35 
Figure 11 Mol% proportions of diacyl PE detected in the BMSC samples from early to 
late passages of five aged donors. ....................................................................................... 35 
 8 
Figure 12 Mol% proportions of alkenyl-acyl PE detected in the BMSC samples from 
early to late passages of five young donors. ....................................................................... 36 
Figure 13 Mol% proportions of alkenyl-acyl PE detected in the BMSC samples from 
early to late passages of five aged donors. ......................................................................... 37 
Figure 14 Mol% proportions of PS detected in the BMSC samples from early to late 
passages of five young donors.............................................................................................. 38 
Figure 15 Mol% proportions of PS detected in the BMSC samples from early to late 
passages of five aged donors. ............................................................................................... 38 
Figure 16 Mol% proportions of PI detected in the BMSC samples from early to late 
passages of five young donors.............................................................................................. 39 
Figure 17 Mol% proportions of PI detected in the BMSC samples from early to late 
passages of five aged donors. ............................................................................................... 40 
Figure 18 Ratio of PI totals to PS totals (PI: PS) on mol% basis of the BMSC from early 
to late passages in young donors. ........................................................................................ 41 
Figure 19 Ratio of PI totals to PS totals (PI: PS) on mol% basis of the BMSC from early 
to late passages in aged donors. .......................................................................................... 41 
Figure 20 Main molecular PC diacyl species on mol% basis (means of five replicates ± 
SD) of means of initial (Pi) and final passages (Pf) of the BMSC from five young donors.
 ................................................................................................................................................ 42 
Figure 21 Main molecular PC diacyl species on mol% basis (means of five replicates ± 
SD) of means of initial (Pi) and final (Pf) passages of the BMSC from five aged donors.
 ................................................................................................................................................ 43 
Figure 22 Main PC alkyl species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five young donors. ....................... 44 
 9 
Figure 23 Main PC alkyl species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five aged donors. ......................... 44 
Figure 24 Main PE diacyl species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five young donors. ....................... 45 
Figure 25 Main PE diacyl species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five aged donors. ......................... 46 
Figure 26 Main PE ether species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five young donors. ....................... 47 
Figure 27 Main PE ethers species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five aged donors. ......................... 47 
Figure 28 Main PI species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five young donors. ....................................... 48 
Figure 29 Main PI species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five aged donors. ......................................... 49 
Figure 30 Main PS species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five young donors. ....................................... 50 
Figure 31 Main PS species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five aged donors. ......................................... 50 
Figure 32 Main LysoPC species on mol% basis (means of five replicates ± SD) of means 
of initial and final passages of the BMSC from five young donors. .................................. 51 
Figure 33 Main LysoPC species on mol% basis (means of five replicates ± SD) of means 
of initial and final passages of the BMSC from five aged donors. .................................... 52 
 
 10 
ACKNOWLEDGMENT 
 
First and foremost my heartfelt gratitude and appreciation goes to my supervisor, Reijo 
Käkelä (Dr.) for his valuable guidance and endless patience. Thanks for setting such a 
great example.  
 
This thesis project was funded by Tekes, Human Intelligence Monitoring project as well 
as Finnish Red Cross Blood Service, Research and Development unit. Especial thanks 
goes  to  Saara  Laitinen  (Dr.),  Lotta  Kilpinen  and  Birgitta  Rantala  for  their  smooth  
cooperation and willingness to help. 
 
I am grateful to Pentti Somerharju (Dr.) and his team members for providing working 
space and resources in addition to their advice and valuable comments that made my one 
year stay there more than comfortable.  
 
My heartfelt gratitude goes to Eskinder Tadess-Abdela for not letting me give up on this 
whole journey at the very beginning, thanks for the motivation. 
 
Most importantly to my family for being my rock through and through and to my closest 
friends here in Finland and abroad for the emotional support; I hope to go even further 
with your love and care. Thank you very much! 
 
 
 
 
 
 
 
 11 
1 Introduction 
1.1 Lipids 
Definitions  
Lipids can be defined based on either A) their functionality as ‘‘an important class of 
compounds that have a wide variety of key cellular functions including 
compartmentalization, energy storage, cell signaling, protein trafficking and membrane 
anchoring’’ (Oreši? et al. 2008, van Meer 2005, Vance and Vance 2004), or B) their 
solubility into organic solvents (subdivision into amphiphatic or hydrophobic lipids) and 
origin (hydrophobic chains synthesized either via condensation of malonyl or isoprene 
units) (Fahy et al. 2005). 
1.2 Composition & Classifications  
Though lipids as a class of biological molecules, constitute a highly heterogeneous group 
of substances with a wide variety of structures, nevertheless a common ground exists in 
that all contain a major domain of hydrophobic molecule. Lipids typically contain either 
long hydrocarbon chains, i.e. fatty acids and isoprenes, or multiple linked rings, as in 
steroids (Alberts et al. 2008). The predominant types of interactions common to lipids 
are the van der Waals and hydrophobic effects in addition to their amphipathic nature 
which allows hydrogen bonding and electrostatic interactions. The broad variation in 
structure and biological function of lipids makes the task of classification arbitrary. 
Regardless of this difference, various attempts have been made. For instance, Fahy et al. 
(2005) has broadly classified lipids based on their hydrolysis end-product as either 
‘‘simple’’ lipids for those yielding at most two types of compounds, and ‘‘complex’’ 
lipids which give three or more different products. This classification scheme can further 
be categorized into subclasses (Fig.1) based on the chemical nature and distinct 
hydrophilic elements (i.e. head groups) of lipids.  
 
Triacylglycerols and waxes are representatives of simple neutral lipids formed 
when fatty acid chains esterify hydroxyl groups of glycerol or longer chain alcohols, 
respectively. The triacylglycerols are the major energy reserves enclosed in fat droplets 
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in the cytosol of adipose and other cells, in addition to serving as excellent insulators. On 
the other hand polar lipids such as phospholipids and glycolipids are important 
constituents of cell membranes. The glycerophospholipids’ structure consists of a 
glycerol backbone, two fatty acid chains and a polar alcohol group, such as choline and 
ethanolamine, linked via a phosphate group (Murphy & Axelsen 2010). Sphingolipids 
constitute a class of complex lipids which have sphingosine alcohol for a back bone 
instead of glycerol. This lipid class plays an important role in structural and regulatory 
actions of cell membranes (Ozbayraktar et al. 2009). Last in this classification, the 
glycolipids constitute those complex lipids that are derivatives of ceramides just like the 
sphingomyelines but differ in their hydrophilic headgroup which is composed of 
saccharides. Glycolipids, situated in the outer surface of the plasma membrane function 
as antigens and receptors, assist cell-cell adhesion, modulate signal transduction along 
with performing the essential task of organizing and sorting membrane proteins 
(Hakomori 2008, Sprong et al.2001).  
 
 
 
 
Figure 1 Schematics of Classification of the Most Abundant Cellular Lipids (Adapted 
from Pursell, D. P. 2009)  One or more saccharide groups  
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The glycerophospholipids, of special interest to this study, contain various types 
of glycerol-alkyl chain linkages such as ester, ether and vinyl ether bonds which account 
for the additional diversity among its class (Yetukuri et al. 2010). Their amphiphilic 
nature comes as a consequence of replacing one of the fatty acids in a triacylglycerol 
with a polar group (Lindblom 2005). Glycerophospholipids are further diversified by the 
alteration of their polar head group into the following: 
 
Phosphatidylcholines (PC) – the most abundant phospholipid and the key membrane 
building block. Approximately 50% of the total phospholipid present in membranes of 
most animal tissues is PC, a neutral zwitterionic phospholipid, which makes up the 
majority of the outer leaflet of the plasma membrane (Deenen 2006). PC also serves as 
the biosynthetic precursor for sphingomyelin, phosphatidic acid, 
lysophosphatidylcholine and platelet-activating factor (Vance & Vance, 2004).  
 
Phosphatidylethanolamine (PE) – the second most abundant phospholipid in a 
mammalian cell constituting approximately 15% – 25% of the total (Meer 2005). It is 
also a neutral zwitterionic molecule with a conical geometry due to its small sized polar 
headgroup (Dowhan 1997). Membrane fusion and maintenance of the functional 
structure of integral membrane proteins is mainly attributed to non-bilayer forming lipids 
like PE (Dowhan 1997). PE contributes to the lateral pressure by introducing some stress 
or strain in the membrane bilayer as a direct consequence of its small head group and 
conical shape. Consequently this influences membrane proteins’ conformation and their 
functionality as well (Kruijff 1997, Landau & Rosenbusch 1996, Marsh 2007). 
 
Phosphatidylserine (PS) – quantitatively a minor class of the membrane 
glycerophospholipids, PS amounts to 2% - 10% of the total phospholipids in a typical 
mammalian cell (Vance & Steenbergen 2005). PS is predominantly located on the 
cytosolic leaflet of the plasma membrane along with PE and PI (Farooqui & Farooqui 
2009). Subsequently, its appearance in the outer leaflet is an apoptotic signal for 
clearance of cell corpses by phagocytosis (Fadok et al. 2000; Züllig 2007). Moreover, 
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PS acts as an essential cofactor and activator of protein kinase C in the presence of Ca2+ 
and sn-1, 2-diacylglycerol (Bell 1991). 
 
Phosphatidylinositol (PI) – exclusive to eukaryotes, this group of phospholipids makes 
up around 5% of membrane lipids (Vance 2002). These are acidic phospholipids with a 
phosphatidic acid backbone that were first recognized for their role as precursors of 
secondary messengers. This function is a direct result of PI’s unique ability to be 
reversibly phosphorylated at three distinct positions (Wymann & Schneiter 2008). 
Products of this phosphorylation then serve as second messengers that initiate activation 
of  protein  kinases  and  release  of  Ca2+ as signaling cascades. Furthermore, soluble 
inositol polyphosphates (PIPs), mainly inositol 1, 4, 5-trisphosphate, have various 
functions ranging from gene transcription and RNA editing to modulation of cell growth, 
proliferation and protein phosphorylation (Paolo & Camili 2006). Phosphoinositides 
ability to generate constitutive signaling is employed as a detection code that is needed 
to define organelle identity. This characteristic stems from its ability to cooperate with 
one or more additional binding sites within the membrane forming a very stable 
membrane-protein interaction which in turn serves as a detection code in regulation of 
membrane-cytosol interactions and thus for the definition of organelle identity (Paolo & 
Camili 2006).  
 
Lysophosphatidylcholine (LysoPC) – is a polar phospholipid generated from partial 
hydrolysis of PC by the enzyme phospholipase A2. Studies have shown that LysoPC 
functions as an immunomodulatory agent by inducing the expression of multiple genes 
essential for inflammatory action in variouse cell-types such as endothelial and T- cells 
(Matsumoto et al. 2007). As one of the essential lipid components of plasma, LysoPC 
assists in the transport of polyunsaturated fatty acids and choline to tissues. On the other 
hand, LysoPC can also have cytotoxic effects if its level is not regulated causing 
pathological conditions such as ischaemia and aretherosclerosis (Croset et al. 2000).  
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Table 1 Structure of major phospholipid classes (modified King 2011) 
 
 
1.3 Functions of lipids 
Whereas proteins and genes are known to be very specific to the functions they perform, 
lipids on the other hand as membrane building blocks and fat depots, have been thought 
to play a fairly nonspecific role (Mouritsen 2005). This biased concept of lipids comes 
from the lack of an obvious link between molecular structure and function as compared 
to proteins whose function is readily governed by their structure. However, this view has 
changed considerably in recent years and now the central biochemical importance of 
lipids expands far beyond what was first presumed.  
Phosphatidylcholine (PC) 
 
 
Phosphatidylethanolamine (PE) 
 
Phosphatidylserine (PS) 
 
Phosphatidylinositol (PI) 
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1.3.1 Lipids as Building Blocks 
Lipids are most commonly recognized for their role in building membrane bilayers by 
self-assembly processes (Mouritsen 2005). Although biological membranes differ 
greatly in function and lipid composition, they all have the same basic construction 
principle consisting of a lipid bilayer into which proteins are inserted in a unique 
orientation (Tamm et al. 2002). These lipid bilayers of living cells are responsible for 
providing the fundamental architecture that delineates boundaries as well as for 
interactions  of  the  cell  with  its  environment.  Furthermore,  membranes  are  used  to  
compartmentalize cells into different functional units, for protein synthesis and secretion 
and to support signal transduction and vesicular transport via fusion (Fagone & 
Jackowski 2009). The semi-permeable membranes tightly regulate the transport of 
various solutes across the bilayer via passive and active transport mechanisms (Cross 
2001). Perhaps, the most important and recently discovered role of membrane lipids is 
their ability to modulate membrane protein functionality via covalent attachment to 
proteins (Martin 2001). Last but not least lipid bilayers provide communication 
platforms for cells to interact with the extracellular environment through signal 
transduction process mediated by transmembrane proteins (Salvaterra 2001). All this 
diverse functionality of membranes arises from different structural and chemical 
behavior of lipids. 
 
1.3.2 Lipids as Energy Stores 
The role of energy storage in lipids is most evident when considering adipose tissue 
which is the major long-term energy source in mammals. A typical adipocyte contains 
one or more cytoplasmic triacylglycerol-rich lipid bodies or droplets which are 
synthesized in specialized regions of the ER (Murphy & Vance 1999). Lipids are the 
preferred type of energy store because they enable a much larger reservoir of energy 
compared to carbohydrates or proteins. This in turn is a direct consequence of 
triglycerides ability to be stored in anhydrous thus less bulky form in adipose tissue. 
During oxidation of fatty acids ATP is generated yielding an energy source two-fold 
greater than other sources (Tronsted & Berge 2004).  
 17 
1.3.3 Lipids as Signaling Molecules  
After the Singer-Nicholson model (fluid-mosaic) of a uniform plasma membrane was 
proposed, it became evident that eukaryotic cell membranes were of heterogeneous 
composition and that certain lipids and proteins tend to form a more liquid ordered 
phases or micro-domains called lipid rafts (Pike 2009). These dynamic domains can 
sequester a subset of signaling proteins which preferentially partition into them and 
change their local concentration, composition and conformation according to the 
metabolic state of a cell (Rajendran & Simons 2005, Simons & Toomre 2000). 
Furthermore, lipid rafts on the cell surface, enriched with cholesterol and 
glycosphingolipids, have been implicated in such cellular processes as signal 
transduction, membrane trafficking, cytoskeletal organization, and pathogen entry 
(Hanzalbayer & Hancock 2007). The raft domains are ideal platforms for 
transmembrane signaling because many surface receptors tend to associate with them 
upon binding appropriate ligands. For instance, the mammalian inflammatory response 
mechanism sequesters several immune receptors to raft domains upon antigen presence. 
This binding by ligands leads to phosphorylation by Src-family kinases which in turn 
initiate a series of signaling cascades leading to immune cell activation (Cherukuri et al. 
2001, Sedwick & Altman 2002).  In addition, lipid rafts nowadays are implicated to have 
functional significance to different ion channels, which localize within these 
microdomains,  such  as  K+-, transient receptor potential- and Ca2+-channels (Martens 
2004). The mechanism employed by rafts could either be direct through protein–lipid 
interactions or indirect via post-translational modifications (Dart 2010). A common 
example here is PIP2 modulation of ion channels through its ability to connect channels 
to various signaling mechanisms (Hilgemann et al. 2001). The ability of rafts to 
differentially associate signaling proteins with their ion-channel counterparts could serve 
as an efficient cell-surface compartmentalization technique (Martens 2004). Finally, it is 
worth noting that lipids role in cellular signaling extends beyond that of receptor 
activation, to that of a second messenger. For instance, opening of a calcium channel in 
the endoplasmic reticulum is followed by a signaling pathway which leads to receptor 
activation in the plasma membrane. This activates phospholipase C, which in turn 
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cleaves PIPs to produce diacylglycerol and inositol phosphate both of which can act as 
second messengers (Fisher & Jain 2009).  
 
1.4 Lipidomics 
The previous scientific revolution eras, i.e. genomics and proteomics, have resulted in 
major developments towards sequencing genes and identifying the multitudes of protein 
functions. Currently, a third and previously less explored science is coming into the 
metabolomics field, called lipidomics. This field owes its emergence and development to 
the advent of novel mass spectrometric techniques as well as sound theories on the 
structural and functional heterogeneousity of biological membranes. Thus with such 
effective tools, it is now possible to study lipids at the molecular level which in turn 
enables a more in-depth analysis of complex lipid mixtures in various biological 
matrices  and  metabolic  pathways  of  lipids  as  well  as  their  role  in  cell  signaling  
(Fernandis & Wenk 2009). Moreover, modern lipidomics can sensitively identify 
changes in a cell’s lipidome after cellular perturbations (Meer 2005). Consequently, 
lipidomics can now be applied for the development of biomarkers that are indicators of 
certain cellular functions.  
 
1.5 Role of Lipids in Mesenchymal Stem Cells 
Mesenchymal stem cells (MSCs) belong to multipontent type of adult stem cells which 
can differentiate to several cell lineages including osteocytes, chondrocytes, myocytes 
and adipocytes (Rubio et al. 2005). The plasticity of these cells makes them excellent 
candidates for tissue regeneration processes for normal turn-over, and to repair diseased 
or aging tissues (Mangi et al. 2003, Horwitz et al. 2002). Furthermore, MSCs can 
provide important cues for cell survival in damaged tissues, and also modify the 
response of immune cells (Blanc & Pittenger 2005). However, despite the extensive 
progress on their isolation and differentiation techniques, the full potential of MSCs is 
not yet realized due to the fact that there are still no reliable or consistent cell markers 
available for the identification of mesenchymal stem cells (Minguell et al. 2001).  
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Besides, gene expression and surface markers may differ between the original cell 
population and expanded MSC pool.  
 
At present, lipidomics research aims to assist in the discovery of biomarkers in 
order to guarantee the proper identification and isolation of MSCs in addition to genomic 
and proteomic markers. There is evidence showing that the phospholipid composition of 
cells, especially that of stem cells, changes significantly during apoptosis (Fuchs et al. 
2007, Xu 2000). Such cellular profiles can thus serve as a reliable measure of cell 
integrity as well as stem cell differentiation that can assist in the proper identification 
and separation of MSCs from other progenitor cell population (Fuchs et al. 2008).  
 
1.6 Objectives 
Eukaryotic cells’ ability to interact with their external environment is mainly governed 
by the membrane localization and function of several signaling proteins which in turn 
are dependent upon their covalent modification by specific membrane lipids. This same 
phenomenon is also partly responsible for regulating proliferation, differentiation and 
migration of stem cells, which are the current focus of regenerative medicine. In order to 
accomplish this however, it is first necessary to understand the characteristics of stem 
cells, with regards to differentiation and proliferation potential.  Therefore, there is a 
need for the efficient identification and isolation of a specific cell population, i.e. 
ascertain the stem cell identity before transplanting processes.  
This project aims to provide potential characteristic BMSC biomarkers that can 
properly identify these pluripotent cell lines from the residual cells. The proposed 
hypothesis for this project was that compositional changes in stem cell lipidome profile 
from early to late passages could be a possible indicator of aging of the cells. Based on 
this, the main aim of the project was to identify healthy functional human mesenchymal 
stem cells. The specific goals for this thesis work were the following;  
 
? Determine the phospholipid profile of the studied BMSC lines at class level 
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? Determine the species profile of the selected major phospholipid classes in 
each BMSC line and between the young and old donors as well. 
? Perform a comparative analysis of the above data to be able to detect lipidome 
changes from early to late passages of the hBMSC  
? Find functional implications for the observed lipidome changes from early to 
late passages of hBMSC. 
 
Previous work on the lipidomics of stem cells has been insufficient to study the 
effects of sequential passaging on MSCs’ phospholipid profile. Comparative analysis of 
stem cell lipidome profiles associated with a specific physiological condition, such as 
aging of the cells, can provide key markers for their functional stages. Furthermore, 
these types of biomarkers are essential for qualitative control of MSCs products, which 
in turn determines the effectiveness and patient safety during transplantations.  
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2 Materials and Methods 
 
Human bone marrow mesenchymal stem cell lines (BMSC) were acquired from Red 
Cross Blood Service research and development department for this study. The BMSC 
samples were harvested, after informed consent, from  ten individuals of which five were 
between the ages of 62 to 82 years (mean 74.6years) and the remainder five came from 
younger donors all under the age of 25 years (mean 23.2years). For the protection of 
anonymity the cell lines were coded 164, 172, 194, 268 & 271 for older donors and 81, 
88, 89, 91 & 92 for younger donors. The BMSC cells were harvested up to 10 passages 
for cell lines 164, 172, 194, 91 & 92; cell lines 81 & 88 up to 12 passages; and the 
remaining cell lines 268, 89 and 271 were cultured up to 8, 9 and 14 passages 
respectively. The cell culturing was stopped when cells start dividing at a much slower 
rate and eventually senescence was reached. The cell pellet samples were marked with 
their codes and passage numbers. It should be noted that prior to cell culturing it was 
demonstrated at the Red Cross Blood Service that the BMSC were able to proliferate and 
subsequently differentiate (in-vitro) into different mesenchymal cell types, such as 
adipocytes, myoblasts, chondrocytes, tendon cells and osteoblasts.  
 
2.1 Tissue Culture 
BMCS samples were thawed at passage four and maintained in growth medium 
containing the following reagents; 86% ?-MEM, 2% 1M HEPES buffer, 10% fetal 
bovine serum certified (FBS/msc), 1% Penicillin – Streptomycin 10000 U/ml and 1% L-
Glutamine 200mM (100X), all purchased from Gibco Invitrogen, Paisely, U.K. The 
samples were plated into 75cm2 tissue culture flasks and maintained in the above 
mentioned growth medium at 37°C in a humidified atmosphere of 5% CO2 and 95% air. 
The medium was removed and cultures were washed with Ca2+ and Mg2+ free phosphate 
buffered saline (PBS; Gibco), after waiting for two days that is needed to ascertain the 
cell-attachment. The cell culture continued for up to three weeks (late passages), 
meanwhile changing the medium twice a week until 70% - 80% confluence was reached. 
The cells were sub-cultured further at density of 1000 cells/ cm2, from passage 4 until 
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senescence was attained. For lipid analysis, the human MSCs were washed with ice-cold 
phosphate-buffer saline (PBS), scraped on ice and transferred to silylated tubes. The 
adherent cells were detached using trypsin-EDTA solution (Gibco).  
 
2.2 Total Lipid Folch Extraction 
The cultured cells were stored at -70°C for a period of 4 to 8 months. The total lipids for 
each sample were extracted according to Folch et al. (1957). Initially the cell pellets 
were removed from the cold storage unit and allowed to warm up to room temperature.  
Next 400 µl millipore water was added to the cell pellet inside the kimax tube and vortex 
mixed. Consequently 3ml Methanol and 6ml Chloroform were enumerated onto the 
mixture and vortex mixed thoroughly after each addition. The solution was then 
incubated in the dark for 30 minutes, so as to let the lipid enter the solution, before 
centrifuging at 3000 rpm for 10 minutes that helped in precipitating the proteins to the 
bottom. The resultant clear supernatant was transferred into another tube and additional 
1.8ml millipore water was put in and vortex mixed. Again this solution was centrifuged 
at 3000 rpm for 10 minutes resulting in the separation of the solution into upper and 
lower phases. The lower chloroform phase containing the lipids was transferred into 
another kimax tube and 4.5ml theoretical lower phase (Chloroform/Methanol/Water 
86/14/1 by volume) was added to the remaining upper phase and vortex mix. This 
mixture was centrifuged for 10 minutes at 3000rpm and the resultant lower phase was 
extracted and mixed with the previous lower phase. Finally, the solution was evaporated 
to dryness under nitrogen flow, 1.5ml Chloroform/Methanol 1:2 were added 
immediately, and the sample solution was stored in a silylated vial in a freezer.  
 
2.3 Lipid Standards  
The MS instrument response for different head group classes varies greatly depending 
on many structural features of lipids, overall lipid concentration, solvent composition 
and instrument settings (Koivusalo et al. 2001). The fact that such a variety of factors 
affected the instrument response necessitated the addition of several internal standards 
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for each phospholipid class in order to obtain truly quantitative data. The dependency of 
the instrument response on variable chain length was corrected by including both short 
and long chain standards for each class of lipids analyzed. Moreover, the standards 
selected were mainly di-unsaturated molecular species mimicking the average degree of 
unsaturation of the natural lipid species as close as possible. This measure is to ascertain 
correct calibration of the instrument response. The internal standards (Table  1) were 
added to the solution prior to infusion. 
 
 
Table 2 Lipid species included in the cocktail of internal standards  
 
 
Lipid  
Standards 
Monoisotopic 
molecular weight 
(m/z) 
Concentration 
(pmol/?l) Source 
PC 14:1/14:1 674 50 
Avanti Polar Lipids 
(Alabaster, AL, USA) 
PC 20:1/20:1 842 50 
PC 22:1/22:1 898 50 
PE 14:0/14:0 636 30 
PE 22:1/22:1 856 30 
Synthesized 
(Phospholipase D mediated  
transphosphatidylation) 
PS 14:1/14:1 676 10 
PS 20:1/20:1 842 10 
PI 18:1/18:1 863 5 Avanti Polar Lipids (Alabaster, AL, USA) 
PI 17:0/14:1 793 5 Lipid Maps (via Avanti Polar Lipids) 
LysoPC 14:1 465 5 Avanti Polar Lipids 
(Alabaster, AL, USA) LysoPC 22:1 577 5 
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2.4 Triple quadrupole Mass Spectrometry (Tandem MS/MS)  
The samples were stored at -70°C for a period of 2-3 months. The lipid molecular 
species profiles were analyzed by ESI tandem MS using a triple quadrupole instrument 
(Micromass Quattro Micro, Manchester, UK).  The solution, containing the sample, 
along with the standard mix, NH3 and Chloroform/Methanol solvent, was introduced 
into the equipment using a Harvard syringe pump at a rate of 7µl/min. The addition of 
NH3 helps in the ionization of certain lipids and prevents formation of Na adducts (those 
molecules that are ionized by the addition of a sodium cation Na+ rather than a proton 
H+). The sample solution was infused into a bath gas at the tip of a thin capillary set to a 
very high voltage (4kV, either positive or negative). Consequently a charged spray is 
formed. The lipids at the surface of the evaporating droplets of the spray get ionized and 
travel down a pressure and potential gradient towards the vacuum orifice and finally 
enter the mass analyzer parts.  
 
 
 
Figure 2 Scanning modes of analysis in a triple-quadrupole mass spectrometer. (Adapted from 
Graves & Haystead 2002) 
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This MS/MS instrument is equipped with three quadrupoles (Fig.1) of which the 
first (MS1) and the last one (MS3) act as mass analyzers while the second quadrupole 
(MS2) operates as a collision cell.  In the case of single-stage MS mode only MS1 or MS3 
operate to produce positive or negative mass spectra of molecular ion species of polar 
lipids only. If collision induced dissociation results in A) loss of the head group as a 
charged fragment then the preferred scanning is the Precursor Ion mode in which the 
second mass analyzer (MS3) is set to transmit only ions of the m/z value of the selected 
fragment ion and the first mass analyzer (MS1) scans precursor masses. On the other 
hand if collision induces B) loss of the head group as a neutral fragment then Neutral 
Loss scanning mode is the preferred detection type. Here both mass analyzers i.e. MS1 
& MS3 scan simultaneously in a synchronized fashion however MS3 scans at a set offset 
from the first one. This offset is equivalent to the characteristic neutral loss for that 
specific class of compound. The samples were analyzed using internal standards and the 
aforementioned class specific detection modes, i.e. Precursor ion and neutral loss scans 
(Table 2). The selected scanning mode, detecting either a neutral fragment or fragment 
ion is characteristic to the lipid class of interest. Source temperature was maintained at 
80?C and each run took approximately 3minutes. 
 
 
Table 3  Summary of the phospholipid class-specific scan modes  
 
Specificity 
 
Polarity 
Scan 
Mode 
MS 
Range (m/z) 
Collision 
Energy 
Capillary 
Energy 
PC & LysoPC Positive P 184 400 - 950 35 3.8kv 
PE Positive NL141 600 - 900 19 3.8kv 
PS Negative NL87 660 - 900 27 4.0kv 
PI Negative P241 720 - 940 70 3.7kv 
P= precursor ion scan, NL = neutral loss scan 
 
 26 
2.5 Data Analysis  
In quantitative mass spectrometric analysis of lipids the rate-limiting step, irrespective of 
the method used, is often data analysis (Koivusalo et  al. 2001). The paragraphs below 
include explanations for the steps taken and the MS software applied to remedy this 
limitation.  
 
2.5.1 Acquisition of MS data  
A software known as MassLynx 4.0 (Waters Corp. Milford, MA) controlled the triple 
quadrupole MS as well as the data acquisition process. A new project file was created 
which contained the method files that configured the instrument settings for each type of 
detection and data acquisition used for the BMSC samples. The MS method settings 
were adjusted to six different modes i.e. MS+, MS- and the four class specific scan 
modes mentioned in Table 1, before the process of data acquisition was set to start. The 
data were represented by a 2-dimensional contour map, whereby the mass-to-charge 
(m/z) is plotted on the x-axis while the intensity is drawn on the y-axis. 
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Figure 3  MS/MS spectra of cell line 271 at passage 8 taken from MassLynx 4.0 the 
spectra are overlaid and partial with mass range of 700m/z – 900m/z. 
 
 
2.5.2 MS data analysis  
The huge amount of data gathered by this analytical instrument was processed by a 
program called “LIpid Mass Spectrum Analysis”, LIMSA (Haimi et al. 2006).  The 
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standard data processing steps that followed include peak detection, lipid identification, 
isotope correction of 13C (one of the naturally occurring isotopes of 12C with one atomic 
mass unit higher), detector response correction and quantification. Initially the raw data 
are exported to Microsoft Excel having LIMSA as an add-in program, which finds and 
integrates peaks in the mass spectrum pasted as list of masses and peak intensities. This 
program with its convenient user interface works as a Microsoft Excel add-in program 
and consists of dynamic library, written in ANSI C++, for identification, deconvolution, 
and quantification of lipid species from MS data. A list consisting of compounds with 
names, sum formulas and isotope abundances for relevant atoms obtained from the 
internal lipid database, as well as quantities of internal standards are prepared as part of 
the input for the LIMSA program. Peak finding and deconvolution of the overlapping 
peak patterns are done to obtain the corrected peak areas of the individual lipid species. 
The problem of isotopic overlap of lipids having mass values close to each other is 
corrected by using different algorithms such as linear fit model or Gaussian peak model. 
Finally, the found compounds and their concentrations are presented on a sheet in 
graphical and tabulated form.  
 
2.5.3 Statistical analysis  
Relevant information was extracted from the available multivariate data matrix using a 
type of applied mathematical modeling approach known as Principal Component 
Analysis  (PCA)  available  in  a  software  package  SIRIUS  6.0  and  7.0  (Pattern  
Recognition Systems, Bergen). This unsupervised method of mathematical modeling for 
exploratory analysis is useful to identify patterns or capture trends in high dimension 
data when there are correlated variables. PCA also helps in expressing the data in such a 
way that it highlights their similarities and differences by reducing the number of 
dimensions of the data without much loss of information. This reduction is brought 
about by creating new set of variables which are linear combinations of original 
variables finally resulting in specific principal components. The resultant principal 
components are independent and uncorrelated to each other with the first one set in the 
direction of the greatest variance in the data. Meanwhile, subsequent components are 
constructed orthogonal to the previous principal component in the direction of largest 
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remaining variance, with each new component accounting for progressively smaller and 
smaller amounts of variance. A principal component analysis proceeds in this fashion till 
the end, finally resulting in components that display varying degrees of correlation with 
the observed variables while at the same time remaining uncorrelated with one another. 
In addition to multivariate data analysis, an independent samples t-test was conducted to 
compare phospholipid species mol% values in initial passages and final passages of 
BMSC from young and aged donors.  
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3 RESULTS 
BMSC samples obtained from the ten young and aged donors were subjected to ESI-MS 
and statistical analysis. Tandem MS produced ion spectra that are generated from two 
types of fragment peaks upon collision: headgroup fragment peak as in the case of PC, 
LysoPC and PI; or fragment peak detected from the neutral loss of the headgroup as in 
PE and PS. Exception was made to PEe which had no specific detection mode and thus 
these lipids were detected by using single stage scans in negative ion mode. The 
immense amounts of ion spectra or data acquired from ESI-MS were further statistically 
analyzed by the MassLynx and LIMSA programs to yield mol% profiles. Subsequently 
lipidome profiles for the BMSC samples’ phospholipid class and their species were 
obtained. 
 
3.1 BMSC Lipid Class Profile 
The phospholipid class compositions for the BMSC samples from the young and 
aged donors were studied separately (Figs. 4, 5). The class totals were summations of 
mol% of individual molecular species from each phospholipid group identified in a cell 
line. Zwitterionic phospholipids PC (40-55%) and PE (34-48%) were the main 
phospholipid classes present in the BMSC samples. The remaining PI, PS and LysoPC 
classes had a relatively smaller portion (9-18%).   
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Figure 4 Mol% proportions of phospholipid classes detected in the BMSC samples from 
early to late passages of five young donors. 
 
 
 
Figure 5 Mol% proportions of phospholipid classes detected in the BMSC samples from 
early to late passages of five aged cell lines. 
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 Diacyl PC in the young BMSC had a higher mol% (>36) in most of its cell lines’ 
initial passages when compared to similar passages of the older groups (< 36 mol %). 
Two of the young cell lines, 81 and 88 showed an increasing mol% towards their final 
passages (Fig.  6); in contrast, cell lines 89 and 91 had a lower value at their latest 
passages. Cell line 92 maintained its diacyl PC levels at a constant throughout its four 
passages.  In the older BMSC (Fig. 7) most of the cell lines had an elevated mol% levels 
at the final passages with the exception of cell line 172. However, their earliest passages 
had a lower mol% (<36%) in comparison to the young BMSC counterparts. Ether-linked 
lipids such as alkyl-acyl PC make up one fifth of the overall phospholipids classes (Figs. 
6, 7) and the total concentration had fluctuating levels between different cell lines. 
Despite this fluctuation, the PC total pool was relatively well conserved in both cell 
lines. 
 
 
 
Figure 6 Mol% proportions of diacyl and alkyl-acyl PC detected in the BMSC samples 
from early to late passages of five young donors.  
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Figure 7 Mol% proportions of diacyl and alkyl-acyl PC detected in the BMSC samples 
from early to late passages of five aged donors. 
 
 
LysoPC, present in trace amount, increased towards late passages of BMSC from 
the young cell lines (Fig.8) reaching upto 2% on average. However, cell line 91 showed 
a much higher level at similar passages. In contrast, the aged donors’ profile of 
consecutive passages (Fig.9) showed wider individual variation. Cell lines 172, 268 and 
271 all had an elevated late passage mol% while cell lines 164 and 194 had the reverse. 
Furthermore, initial levels at passage 4 were in general higher in the samples from aged 
donors than from young ones (Figs. 8, 9). 
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Figure 8 Mol% proportions of LysoPC detected in the BMSC samples from early to late 
passages of five young donors. 
 
 
 
Figure 9 Mol% proportions of LysoPC detected in the BMSC samples from early to late 
passages of five aged donors. 
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Diacyl PE levels in BMSC of both the young (Fig. 10) and aged donors (Fig. 11) 
showed a rather decreasing trend from the early to late passages.  
 
 
 
Figure 10 Mol% proportions of diacyl PE detected in the BMSC samples from early to 
late passages of five young donors. 
 
 
Figure 11 Mol% proportions of diacyl PE detected in the BMSC samples from early to 
late passages of five aged donors. 
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Alkenyl-acyl PE constitutes a considerable amount of the total phospholipids 
detected in the BMSC. The young cell lines’ profile (Fig. 12) had an ascending molar 
percentage towards late passages with an almost two fold increase in the case of cell line 
92. On the other hand the aged donors’ (Fig.13) had a highly fluctuating profile even 
though the overall concentration was maintained below 24mol% in most cases. 
Nevertheless, the general trend seen was a decreasing one towards final stages.   
 
 
 
Figure 12 Mol% proportions of alkenyl-acyl PE detected in the BMSC samples from 
early to late passages of five young donors. 
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Figure 13 Mol% proportions of alkenyl-acyl PE detected in the BMSC samples from 
early to late passages of five aged donors. 
 
 
The aminophospholipid, PS constituted less than 10% of the total phospholipid 
extracted from the BMSC samples. Young donors (Fig. 14) exhibited a decreasing mol% 
from initial to final passages with the exception of cell lines 88 & 89 which had a 
relatively stable profile. BMSC from cell line 81 passage 4 had an abnormal level of PS 
(>10%) which might be due to artifacts. The aged donors (Fig. 15) had varying mol%; 
the first three cell lines (164, 172, and 194) increased their mol% from passage 4 to the 
final passage 10. In contrast, the last two cell lines (268 and 271) had a decreasing mol% 
when comparing initial to final passages.  
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Figure 14 Mol% proportions of PS detected in the BMSC samples from early to late 
passages of five young donors. 
 
 
 
Figure 15 Mol% proportions of PS detected in the BMSC samples from early to late 
passages of five aged donors. 
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PI profiles for both young (Fig. 16)  and  aged  (Fig. 17) cell lines illustrate an 
enhanced mol% towards late passages. However, this trend is not consistent throughout 
individual passages but highly fluctuated between initial and final passages for both the 
aged as well as young BMSC samples. Cell line 172 distinctively had an abnormal level 
of PS at its final passage exceeding 10%.  
 
 
 
Figure 16 Mol% proportions of PI detected in the BMSC samples from early to late 
passages of five young donors. 
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Figure 17 Mol% proportions of PI detected in the BMSC samples from early to late 
passages of five aged donors. 
 
 
PI which made up less than 10mol% of the total phospholipid classes was 
contrasted against PS classes to detect a simpler pattern (Figs. 18, 19). The resulting 
profile ascertained the previous findings of a decreasing value for PS accompanied by an 
increment of PI levels. The ratio of PI: PS rose to more than 1% shortly before the last 
passage in most cases of the young BMSC cell lines (Fig. 18). 
 
Phosphatidylinositol?(PI)
0
2
4
6
8
10
12
14
16
p4 p6 p8 p1
0 p4 p6 p8 p1
0 p4 p6 p8 p1
0 p4 p6 p8 p4 p6 p8 p1
0
p1
2
p1
4
164 172 194 268 271
Aged?Donors
M
ol
%
PI
 41 
 
Figure 18 Ratio of PI totals to PS totals (PI: PS) on mol% basis of the BMSC from early 
to late passages in young donors. 
 
 
 
 
Figure 19 Ratio of PI totals to PS totals (PI: PS) on mol% basis of the BMSC from early 
to late passages in aged donors. 
PI:PS
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
p4 p6 p8 p1
0
p1
2 p4 p6 p8 p1
0
p1
2 p4 p6 p8 p9 p4 p6 p8 p1
0 p4 p6 p8 p1
0
81 88 89 91 92
Young?Donors
M
ol
%
PI:PS
PI:PS
0.0
0.3
0.6
0.9
1.2
1.5
1.8
2.1
2.4
p4 p6 p8 p10 p4 p6 p8 p10 p4 p6 p8 p10 p4 p6 p8 p4 p6 p8 p10 p12 p14
164 172 194 268 271
Aged?Donors
M
ol
%
PI:PS
 42 
3.2 BMSC Molecular Species Profile in each phospholipid class 
Concurrent to developing the lipidome profile at phospholipid class level, analysis of 
alterations in molecular species level were also carried out for individual BMSC donors 
and their respective passages. The large number of phospholipid species included in the 
analysis work is presented in the figures below. However, the mol% listed below 
represent the average of a specific species’ total from initial passages and final passages 
likewise. T-test calculations have been performed to evaluate the difference between the 
means from the initial and late passages.  
 
3.2.1 Phosphatidylcholine diacyl (PC) species  
PC diacyl species of the studied BMSC samples from both young (Fig.20) and aged 
(Fig.21) donors had a strikingly similar profile in that a decrease in saturated and 
monounsaturated short acyl chained species such as 32:0, 32:01, 34:0 and 34:01 was 
observed towards latest passages. This trend was counter-balanced by an elevation of 
long acyl chain and polyunsaturated species 36:01, 36:04, 38:03 and 38:04.  
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Figure 20 Main molecular PC diacyl species on mol% basis (means of five replicates ± 
SD) of means of initial (Pi) and final passages (Pf) of the BMSC from five young 
donors.  ? statistical difference at p<0.05 level, t-test  
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Figure 21 Main molecular PC diacyl species on mol% basis (means of five replicates ± 
SD) of means of initial (Pi) and final (Pf) passages of the BMSC from five aged donors. 
 
 
3.2.2 Phosphatidylcholine ether lipid (PCe) species  
PC alkyl mol% profiles in the young (Fig.22) and aged donors’ (Fig.23) emulated each 
other as well as PC diacyl species profile. The quantitatively prevalent species 34:1 
made up approximately 20% of the total alkyl-acyl PC species in the initial passages but 
later was reduced to nearly 16% in the final passage. This decrease appeared to be 
compensated by an increase in polyunsaturated long acyl-chain species specifically 38:4 
and 40:2.   
 
Phosphatidylcholine?Diacyl?(PC)?species
0
4
8
12
16
20
24
28
30:00 30:01 32:00 32:01 32:02 34:00 34:01 34:02 34:03 36:00 36:01 36:02 36:03 36:04 36:05 38:01 38:02 38:03 38:04 38:05 38:06
Aged?Donors?
M
ol
%
Avr?Pi Avr?Pf
*
*
*
*
*
*
*
 44 
 
Figure 22 Main PC alkyl species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five young donors. 
 
 
 
 
Figure 23 Main PC alkyl species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five aged donors. 
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3.2.3 Phosphatidylethanolamine diacyl (PE) species  
The profiles of PC and PE diacyl species exhibited comparable trends in their alterations 
from the early to late passages. For instance, short acyl chain molecular species had 
decreased mol% towards final passages in both young (Fig.24)  and  aged  (Fig.25) 
donors’ profile. On the contrary long acyl chain species had a rise in their mol% in the 
latest passages. Furthermore, elevated level of 38:04 in final passages was evident both 
in diacyl PC as well as PE profiles.  
 
 
 
Figure 24 Main  PE  diacyl  species  on  mol% basis  (means  of  five  replicates  ±  SD)  of  
means of initial and final passages of the BMSC from five young donors. 
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Figure 25 Main  PE  diacyl  species  on  mol% basis  (means  of  five  replicates  ±  SD)  of  
means of initial and final passages of the BMSC from five aged donors. 
 
 
3.2.4 Phosphatidylethanolamine ether lipid (PEe) species 
Only unsaturated PEe species were found in the BMSC samples from both groups of 
donors (Fig. 26, 27) with the main species being polyunsaturated: 36:4, 38:4 and 38:5. 
The mol% of these species decreased a significant amount in the end passages but this 
trend was altered in the heavier species with the exception of 40:4 and 40:5 which kept a 
similar decreasing progression. 
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Figure 26 Main PE ether species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five young donors. 
 
 
 
Figure 27 Main PE ethers species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five aged donors. 
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3.2.5 Phosphatidylinositol (PI) species  
The predominant PI species was 38:4 which accounted for about 50% of the total class 
detected in both the young and aged BMSC. The mol% of this species dwindled in the 
final passages. In contrast, short-acyl chained species such as 36:1, 36:2, and 36:4 saw a 
small rise in their mol% during the last passages (Figs. 28, 29).  
 
 
 
Figure 28 Main PI species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five young donors. 
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Figure 29 Main PI species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five aged donors. 
 
 
3.2.6 Phosphatidylserine (PS) species  
About 40% of the total PS was comprised of 36:1 species in both aged (Fig.30) and 
young (Fig. 31) BMSC samples. Again here a common progress detected was a decrease 
in short chain species towards latest passages, accompanied by an elevation in the long 
chain species such as 38:3 and 38:4. Exceptions to this trend were the heavier acyl chain 
species such as 40:4, 40:5 and 40:6.   
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Figure 30 Main PS species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five young donors. 
 
 
 
Figure 31 Main PS species on mol% basis (means of five replicates ± SD) of means of 
initial and final passages of the BMSC from five aged donors. 
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3.2.7 Lysophosphatidylcholine (LysoPC) species  
The vast majority of LysoPC species from the BMSC samples were either saturated or 
monounsaturated ones. The main molecular species was 16:0 (28%) which decreased in 
the final passage. The long acyl chain species 18:0 and 20:4 on the other hand had a final 
higher mol% as compared to initial passages of both cell lines (Fig. 32, 33). However, 
aged donors’ profile differed somewhat from the young ones because the mol% of 18:1 
decreased slightly in the former one.  
 
 
 
Figure 32 Main LysoPC species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five young donors. 
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Figure 33 Main LysoPC species on mol% basis (means of five replicates ± SD) of 
means of initial and final passages of the BMSC from five aged donors. 
 
 
3.3 PCA 
Multivariate principal component analysis (PCA) was used to study the difference in 
phospholipid composition as a whole among the BMSC from the young as well as aged 
donors. The phospholipid classes were plotted together with BMSC from young and 
aged donors. The PCA biplot (Fig. 34) result demonstrated that the latest passages from 
both young and aged BMSC had a higher level of PI, LysoPC, and PE alkenyl whilst 
earlier passages were mainly rich in PC and PE diacyl classes. Furthermore the latest 
passages were poor in PC diacyl, PE diacyl and PS classes.  
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Figure 34 PCA biplot demonstrating similarities and differences among the BMSC 
samples from both young and aged donors in terms of their phospholipid class 
composition. 
 
 
Fig. 34 Appendage: How to read the PCA biplot? 
The BMSC data studied had different dimensions to be taken into consideration. For this 
purpose a multivariate data analysis technique, PCA was used in order to find the 
various relationships that exist between the data.  PCA highlights similarities and 
differences between data and displays these relationships in a plot as shown above with 
two axes PC1 and PC2. In PCA this high dimension data is compressed with minimum 
loss of information into only two dimensions, PC1 (47.6%) and PC2 (25%) which 
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represented the total variation amongst the ten BMSC lines in terms of their 
phospholipid classes. 
 
PCA assigns PC1 to the direction of the largest variation detected among the 
samples and removes it so that it can then search for the next significant direction of 
variation and assign that to PC2.    In this way, PC1 and PC2 serve as indicators of 
different and independent variables which are responsible for the changes in the 
composition detected in the samples. Thus the biplot is interpreted as follows. Samples 
with similar phospholipid class composition are clustered together. As the distance 
between two BMSC samples (marked red) increases the more they differed in terms of 
their phospholipid class profile. Similarly, the lipid classes (marked blue) are responsible 
for the variations observed in that particular direction. The correlation between the 
BMSC samples and the phospholipid classes are as follows. The further a BMSC sample 
is located from the origin and on the same side of the coordinate plane along with a 
specific lipid class, then this means it is richer in that specific lipid class and poorer in 
those phospholipids that appear on the other side of the plane. The angle formed when 
connecting two different BMSC samples via the origin denotes the degree of 
coincidence of different lipids in all studied BMSC cell lines. (e.g. 0° = total positive 
correlation, 90° = no correlation, 180° = total negative correlation between the mol% of 
those two lipids in the studied cell samples). 
 
In the distribution of variation plot (Fig.35), principal component 1 (PC1) was 
the highest mostly in the latest passages of the BMSC from both the young and aged 
donors. On the other hand, the second principal component was equally significant in 
172p10, 081p4 and 092p10. In BMSC from young donors, most of the variation was 
mainly due to PC1 while in BMSC from aged donors the response differed from cell line 
to cell line as well as through passages. Only cell lines 164p4, 172p10 and 271p4 
behaved similarly to those BMSC from young donors.    
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Figure 35 Distribution of variation in the phospholipid class composition for each 
BMSC sample, for the first three principal components and remaining residuals. 
 
 
 Due to the consistent increase in the totals of 38:4 (PC and PE) species in the 
latest passages from both the young and aged donors, combined PCA analysis of these 
two classes of phospholipids was performed. The results in Fig. 36 clearly indicated that 
latest passages of BMSC from both young and aged donors were rich in PC38:4 and 
PE38:4. Monounsaturated species from both PC and PE classes were found closer to 
earliest passages of young and aged BMSC. The angle formed between the lines 
connecting PC34:1 and PC38:4 via the origin, indicates a near full negative correlation.  
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Figure 36 PCA biplot demonstrating similarities and differences among the BMSC 
samples in terms of their PC and PE species composition. 
 
 
Again in the distribution of variation graph below (Fig. 37), PC 38:4 and PE38:4 are the 
main reason behind the largest variation noted as component 1. Other species such as 
PC34:1, PC36:4, PE34:1 and PE36:1 also contributed to the variations in BMSC in 
terms of their PC and PE species profile change. 
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Figure 37 Distribution of variation in the phospholipid class composition for each 
BMSC sample, for the first three principal components and remaining residuals. 
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4 Discussion 
MSCs’ therapeutic potential emanates from their ability to regenerate damaged tissues, 
which in turn stems from their multipotency nature. However, the low abundance of 
these cells in the most commonly used sources of adult stem cells necessitates in vitro 
expansion. According to several studies, it is during these repeated culturing steps that 
progenitor cells lose their growth as well as differentiation potential (Brown and Dykin 
1991, Fuchs et al. 2007, Tekkatte et al. 2011, Tuan et al. 2003). At the same time the 
phospholipid composition of cells was affected by the passage number along with 
different physiological conditions such as apoptosis induced by aging or inflammation. 
These challenges coupled with the need to ascertain the quality of transplanted MSCs’ 
inspired the current study which was focused on investigating the effect of passaging and 
donor age on MSCs’ phospholipid profile which can be a reflection of their 
functionality.  
 
Phospholipid Classes 
Regardless of donor age, the different BMSC from both young and aged donors 
were characterized by similar lipid class composition (Figs. 1 and 2). The phospholipid 
class proportions were in accordance with those commonly found in mammalian cell 
membranes, with PC and PE being the two predominant classes and others such as PS 
and PI present in smaller amounts (Leidl et al. 2008, Meer 2005).  The results for each 
phospholipid class are discussed below.  
 
PC. Since PC is the most abundant phospholipid in mammalian cells, and the main 
building block of the membrane outer leaflet, its cellular level needs to be tightly 
controlled to maintain the general architecture of cell membranes (Koumanov et al. 
2004). PC is one of the neutral or zwitterionic phospholipids that have the ability to 
readily organize into bilayers due to its cylindrical shape as well as large polar head 
group. These characteristics make it an essential part of the membrane’s outer leaflet the 
primary role of which is to act as a protective shield for cells against the extracellular 
environment. Despite certain individual variations in the PC totals of young and aged 
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donors, mol% levels from early to late passages from both sets of donors were 
maintained  in  general  between  32  -  40%.  The  rate  of  PC  synthesis  via  the  Kennedy  
pathway has been shown to be regulated by biochemical processes, such as selective 
degradation, rather than by actual supervision of certain enzymes’ transcription or 
translation (Sugimoto?et?al??2008). For instance, excess amount of PC is often converted 
to DAG or other phospholipids by an enzyme that catalyses the final steps in the 
Kennedy pathway (Hermansson et al. 2011). In general, the biosynthesis, degradation 
and inter-organelle transport of phospholipids accompanied by the systematic 
coordination between these three processes play a major role in maintaining the lipid 
composition of cellular membranes (Somerharju et al. 2009).  
 
The species profile in this class indicated that of the monounsaturated long-chain PC 
species, 34:1 was the predominant one present in both young and aged BMSC. It also 
revealed a decrease in unsaturated phospholipids such as 34:1 and 36:2 from early to late 
passages (Figs. 20, 21). On the contrary polyunsaturated species 36:4 (16:0/20:4n-6) and 
38:4 (18:0/20:4n-6) increased towards late passages. This pattern was even more evident 
in the combined PCA biplot of PC and PE species (Fig.36) which showed that such 
PUFAs were enriched mainly in the latest BMSC passages from both the young as well 
as aged donors. Abundant relative levels of PUFAs supress the synthesis of 
monounsaturated fatty acids, oleate or palmitoleate especially, by inhibiting stearoyl-
CoA desaturase (SCD), an enzyme that catalyses the addition of the first cis double bond 
into the ?-9 position of the acyl chain (Bené et al. 2001, Sampath and Ntambi 2005). 
Moreover, Miller et al. (2010) recently presented a possible mechanism by which 
phospholipid species composition in a bacterium (Pseudomonas aeruginosa) is 
regulated. The mechanism involves transcriptional regulators which are able to detect 
changes in composition rather than concentration of specific fatty acids. Consequently 
the ratio of unsaturated vs. saturated fatty acids affects the abundance of individual 
phospholipid species using these fatty acids as structural components and indirectly 
plays a key role in the regulation of membrane lipid homeostasis. Furthermore, the shift 
in phospholipid composition in favour of more unsaturated species especially those 
containing 20:4n-6 may indicate the BMSC’ decreased rate of cell proliferation and the 
 60 
activation of certain lipid signalling pathways which are discussed in detail later on 
(Surette et al. 1999). 
 
 PCe.  Unlike diacyl species the totals of PCe for this group of phospholipids did show 
age-related variations (Figs. 22, 23). BMSC’s from young donors gradually decreased 
their alkyl-acyl PC totals towards final passages while the reverse was observed for 
those from aged donors.  An exception to this trend was cell line 271 obtained from an 
aged donor which was able to maintain its alkyl-acyl PC mol% at constant level. 
According to Baburina and Jackowski (1999) increased alkyl-acyl PCs totals interfere 
with the regulated deacylation of excess phospholipids which in turn inhibits normal cell 
proliferation.  Aged BMSC must therefore be exhibiting slower cell growth rates as 
opposed to the young ones which were able to reduce their alkyl-acyl PCs totals towards 
final passages.  
 
LysoPCs. Higher LysoPC mol% was seen in late passages from both the young and 
aged BMSC (Fig.  8,  9). The earliest passages from old donors had double the level of 
LysoPC present in similar passages from young BMSC. Comparison of the LysoPC 
species composition of early to late passages from both young and aged BMSC indicated 
a decrease in palmitic acid (16:0) while in contrast stearic (18:0) and 20:4n-6 levels 
increased. Furthermore, the total 20:4n-6 content of total fatty acids released from 
different phospholipids was increased as well (unpublished data, 2011). As a bioactive 
pro-inflammatory lipid LysoPC can be a vital sign of cellular pathological activities 
(Matsumoto et al. 2007, Colles and Chisolm 2000). As a result higher concentration of 
LysoPC in later passages can be taken as a sign of oxidative stress or an indicator of 
cells diminished capability to fend off inflammation (Tselepis and John 2002, Watanabe 
et al. 2002, Okita et al. 1998). Furthermore, studies have shown that LysoPC 
accumulation causes an increase in the intracellular Ca2+ level with simultaneous 
stimulation of membrane associated protein kinase C (PKC) activity (Su et al. 1995). 
The  influx  of  Ca2+ and associated PKC activity indirectly activate cytosolic 
phospholipase (PLA2) finally resulting in a rapid release of 20:4n-6 (Mayer and 
Marshall 1993, Wong et al. 1998). This is a possible bioactive mechanism by which 
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LysoPC contributes to the generation of pro-inflammatory activity in BMSC from older 
passages.  
 
The species profile for LysoPC and PC emulate one another. This is to be expected since 
hydrolysis of PC by phospholipase A2 produces LysoPC. The predominant fatty acids 
present in both classes of phospholipids were palmitic and oleic acids. Besides, both PC 
and LysoPC mol% profiles had an elevated amount of 18:0 and 20:4n-6 species towards 
final passages in BMSC from both the young and old donors (Figs. 32, 33). As discussed 
above the gradual accumulation of 20:4n-6 towards older passages may indicate 
inflammatory activities and subsequent pathological responses.  
 
PE. BMSC from both young and aged donors (Figs. 10, 11) had declining PE totals 
towards the latest passages. This pattern was consistent in both groups of donors with the 
exception of cell lines 194 and 271, which were able to maintain their PE mol% at a 
constant level throughout. Cellular turnover of PE is maintained by mechanisms 
currently unclear (Vance 2008). Nonetheless, studies conducted using mutant cell lines 
defective in PE biosynthesis, ascertained PE’s essential role in regulating cytokinesis 
and normal cell growth (Dowhan and Bogdanov 2002). Thus the reduced PE mol% 
towards latest passages in both groups of donors may indicate poor cellular growth and 
division. There are more 20:4n-6 containing species in PE as compared to the other 
zwitterionic phospholipid, PC.  In addition 38:4 (18:0/20:4n-6) was the main PE species 
that increased towards late passages in both the young and aged BMSC (Figs. 24, 25). 
Such an increase in 20:4n-6 containing PE species is possibly related to the decline in PS 
mol% which is used as substrate for the synthesis of polyunsaturated PE molecules via 
the PS decarboxylation pathway (Bleijerveld et al. 2007, Stone et al. 1998). PS is the 
major precursor for PE synthesis via its decarboxylation in mitochondria (Voelker 
1990). Thus the decline in PS totals may be responsible for the decreased steady-state 
levels of PE. Overall, the progressive decline of PE totals towards older passages in both 
the young and aged BMSC, may compromise its role in neutralizing the net negative 
charge effect of certain transmembrane proteins (Dowhan 2009).  
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PEe. Latest passages in BMSC from young donors had higher PEe (Fig. 12) while the 
reverse was true for BMSC from aged donors (Fig. 13). However, the overall PE total 
pool for both the BMSC from young and aged donors was primarily composed of Pee 
towards older passages. This was in contrast to early passages which contained a higher 
proportion  of  PE  diacyl  species  instead.  Similarly,  of  the  total  PE  pool  present  in  
inflammatory and tumor cells, approximately 70% was comprised of ether lipids (Vance 
2008). A potential function for PEe is to act as sink for polyunsaturated fatty acids 
(Nagan and Zoeller 2001). Indeed the species profiles from the BMSC from young and 
aged donors (Figs. 26, 27) support this view by having 36:4, 38:4 and 40:5 as 
predominant species. Enhanced susceptibility of PEe to oxidative attack indirectly helps 
to protect other phospholipids from similar damage (Zoeller et al. 1999, Brites et al. 
2004, Wallner and Schmitz 2011). This role of PEe as scavengers of reactive oxygen 
species could explain the need to increase their molecular levels as seen in the latest 
passages of BMSC from aged donors. Thus, theoretically the inability of BMSC from 
aged donors to up regulate PEe synthesis may suggest higher oxidative stress.   
 
PI. An increase in the cellular levels of PI from early to late passages was evident in 
both BMSC from young as well as aged donors (Figs. 16, 17). Since 20:4n-6 is the 
primary precursor in the de novo synthesis of PI (Nuwayhid? et?al??2006), enhanced 
levels of PI could be linked with increased levels of LysoPC liberating 20:4n-6 as 
mentioned above. Characteristic to animal cells studied previously the BMSC from both 
young and aged donors (Figs. 28, 29) had a high content of 18:0 and 20:4n-6 species. 
Consequently, PI is taken to be the primary source of arachidonic acid in animal cells. 
This freed 20:4n-6 in turn is required for the synthesis of eicosanoids and prostaglandins 
by the action of phospholipase A2 (Zhou and Nilsson 2001). Furthermore, the ability of 
PI to be phosphorylated at various sites renders it an important precursor for several 
second-messenger molecules such as inositol 1, 4, 5-trisphosphate and DAG. Thus PI is 
needed to initiate different lipid signaling pathways that affect proliferation and 
differentiation of cells and contribute to various inflammatory functions (Wymann and 
Schnieter 2008). PI is mainly located in the inner leaflet of the plasma membrane 
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alongside PS. Thus the increase in PI totals as well as in PI: PS ratio asserts the 
enhanced PI-related signaling towards the late passages.   
 
PS. Anionic phospholipids PS and PE are the main amino phospholipids present in the 
internal leaflet of plasma membrane. These two phospholipids also have interrelated 
biosynthetic pathways; PS is made by base-exchange reactions in which polar head 
groups of either PC or PE are replaced by serine, or vice versa, while an alternative 
synthesis route for PE involves the decarboxylation of PS (Kanfer 1980, Bleijerveld et 
al. 2007). The PS totals in cell lines 81, 91, 92 from the young donors and 268 and 27 
from the aged donors (Figs. 15, 16) had lowered mol% in the late passages. On the 
contrary, cell lines 164, 172 and 194 from aged donors had increased PS mol% towards 
the latest passages.  
 
Not much is known about the regulation mechanism involved in neither PS biosynthesis 
nor its decarboxylation into PE in mammalian cells. Several studies speculate that there 
is a feed-back mechanism that keeps PS turn over and level constant (Kuge et al. 1998, 
Vance and Steenbergen 2005). In other words the activities of enzymes that catalyze PS 
synthesis are regulated by the end-product, PS.   Thus several reasons can account for 
the rise and fall in PS totals observed in the BMSC. PS is synthesized mainly from PC 
and to a lesser extent from PE molecules by base-exchange reaction which requires Ca+2 
(Kanfer 1980, Kuge et al. 1998, Stone and Vance 1999). Since PC totals were shown to 
be maintained at a constant level, shortage of PC precursors needed for head group 
exchange reactions can be ruled out as a reason for the observed fall in PS totals. 
However, PS synthesis is also known to be regulated by the docosahexaenoate (22:6n-3) 
levels which decreased towards late passages (unpublished data, 2011) and thus shortage 
of this preferred fatty acid constituent might hinder PS biosynthesis (Gracia et al. 1998). 
A possible alternative explanation for the reduced PS synthesis may be depletion in Ca+2 
from ER stores (Pelassy et al. 1992).  On the other hand, higher concentration of PS, as 
seen in some of the aged donors, may signal over expression of the catalytic enzymes 
involved in the base-exchange reaction as well as inhibition of PS decarboxylation to 
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limit the conversion of PS to PE. Furthermore, studies suggest that this type of increase 
in PS synthesis is characteristic of apoptotic cells (Aussel et al. 1998). 
 
In summary, the phospholipid compositions of the BMSC from both young and 
aged donors were close to earlier records for MSCs (Fuchs et al. 2008, Meer 2005). 
However, certain exceptions did exist in the case of PE totals which had a slightly higher 
mol% at an average of 36% for BMSC from both young and old donors. Phospholipid   
Although the BMSC from the different donors were cultured in similar conditions 
individual variation were expected due to the donors’ age, hereditary reasons, 
physiological condition, diet and other such factors. Consequently, certain differences 
were evident between BMSC from the different donors especially in the totals of 
LysoPC and PS. 
 
The variation in the phospholipid class and molecular species profiles among the donors 
was smaller than that observed between consecutive passages i.e. between early to late 
passages. In general, the early passages maintained the normal cellular phospholipid 
profiles but this regulation was gradually lost towards the late passages. As the 
univariate t-test of single species and the multivariate analyses for example the compiled 
distribution of variation graph for both PC and PE species showed, earlier passages of 
BMSC from both young and aged donors were rich in saturated and monounsaturated 
molecular species (e.g. 34:1, 36:1). Whereas, latest passages were poor in these 
monounsaturated species, they were highly enriched in polyunsaturated species, 
especially 20:4n-6 -containing ones (36:4, 38:4). The biological significance of these 
findings mainly relates to the lipids function as signalling molecules. Upon activation of 
certain lipid signalling pathways, the cellular responses may go in either direction of 
proliferation, differentiation or programmed cell death depending on the type of signal 
received. Several cellular signalling pathways originate in membranes when 20:4n-6 is 
deliberated from phospholipids especially for eicosanoid signalling, of special interest to 
this study.  
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The main precursors for eicosanoid synthesis are PUFAs such as 20:4n-6, which is 
liberated from the sn-2 position of phospholipids by the action of phospholipase A2 
(Buczynski et al. 2009). Upon release 20:4n-6 is subsequently converted to 
prostaglandins, leukotrienes and lipoxins collectively termed as eicosanoids (Cheng et 
al. 2006). These bioactive lipids have different physiological and pathological roles 
including vascular homeostasis, inflammation, cell proliferation and differentiation 
(Harizi et al. 2008). Moreover, eicosanoid biosynthesis increases during inflammation 
whereby they act as chemoattractants and platelet aggregators.  
 
As the main finding supporting lipid-mediated functional changes in the late passages of 
the BMSC, the lipid molecular species profiles and the PCA demonstrated that 20:4n-6 -
containing phospholipids markedly increased towards the late passages. Of particular 
interest were the 38:4 species in both PC and PE profiles which increased their 
proportions from early to later passages. These species of lipids can be used as 
biomarkers that can be monitored in association with MSCs’ passaging or cell aging. In 
addition, another efficient biomarker could be the PI: PS ratio which showed a consistent 
rise throughout sequential passaging. In this perspective lipid’s role as biomarkers assists 
in providing tested, viable and functional cell lines needed to ensure efficient therapeutic 
MSC applications that guarantee patient safety.  
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